C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Citing Need to Assess Potential Risks

An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension’s effect on global needs for a one-shot, easy-to-ship vaccine. BY DENISE GRADY AND CARL ZIMMER By BY DENISE GRADY AND CARL ZIMMER from NYT Health https://ift.tt/3g8fVuZ Health New York Times
via